Pages that link to "Clopidogrel"
Jump to navigation
Jump to search
The following pages link to Clopidogrel:
Displayed 100 items.
- Desirudin (← links)
- Chronic stable angina overview (← links)
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: Oral Antiplatelet Therapy View the Current CLASS IIb Guidelines (← links)
- The Living Guidelines: Oral Antiplatelet Therapy Suggest Revisions to the CLASS IIb Guidelines (← links)
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS I Guidelines (← links)
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS IIa Guidelines (← links)
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS IIa Guidelines (← links)
- ST elevation myocardial infarction pre-hospital care (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy Suggest Revisions to the CLASS IIb Guidelines (← links)
- ST elevation myocardial infarction secondary prevention (← links)
- ST elevation myocardial infarction aspirin therapy (← links)
- The Living Textbook of Cardiovascular Pharmacology (← links)
- ST elevation myocardial infarction thienopyridine therapy (← links)
- ST elevation myocardial infarction glycoprotein IIbIIIa inhibition (← links)
- ST elevation myocardial infarction coronary artery bypass grafting (← links)
- COMMIT-CCS 2 (← links)
- Jacko test (← links)
- Adenosine A1 receptor (← links)
- PCI in the patient in cardiogenic shock (← links)
- ST elevation myocardial infarction primary percutaneous coronary intervention (← links)
- Retroperitoneal hematoma (← links)
- Plasminogen activator (← links)
- TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis (← links)
- Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients (← links)
- High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry (← links)
- Reloading With Clopidogrel Improves Clinical Outcomes in Patients with Acute Coronary Syndromes: ARMYDA-RELOAD (← links)
- High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial (← links)
- Vertebral artery dissection (← links)
- Research on Adverse Drug events And Reports (← links)
- Adenosine A3 receptor (← links)
- P2RY1 (← links)
- P2RY2 (← links)
- P2RY4 (← links)
- P2RY6 (← links)
- P2RY8 (← links)
- P2RY10 (← links)
- P2RY11 (← links)
- P2RY13 (← links)
- P2RY14 (← links)
- P2RX7 (← links)
- Nephrotoxic drugs (← links)
- Otamixaban (← links)
- P2RX5 (← links)
- P2RX2 (← links)
- P2RX4 (← links)
- PCI complications: thrombocytopenia (← links)
- Xience V stent continues to demonstrate superior efficacy over the Taxus stent up to 2 years in the SPIRIT III trial (← links)
- Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel (← links)
- PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference (← links)
- P2RX1 (← links)
- P2RX3 (← links)
- P2RX6 (← links)
- Idraparinux (← links)
- ST elevation myocardial infarction beta blocker therapy (← links)
- Thrombus Aspiration is Associated with Improved 1 Year Mortality Rates in STEMI Patients: the Results of the 1 Year TAPAS Follow-Up Study (← links)
- ACTIVE W Trial (← links)
- Plavix (redirect page) (← links)
- Multivessel coronary artery disease (← links)
- Antithrombin therapy to support PCI (← links)
- List of drugs: Pj-Pra (← links)
- Paroxetine drug interactions (← links)
- Phenytoin drug interactions (← links)
- Hydrocodone drug interactions (← links)
- Glimepiride drug interactions (← links)
- Celecoxib drug interactions (← links)
- Aggrenox drug interactions (← links)
- Amlodipine and Atorvastatin drug interactions (← links)
- Naproxen drug interactions (← links)
- Duloxetine drug interactions (← links)
- Clarithromycin drug interactions (← links)
- The list of drugs may cause diarrhea (← links)
- Bristol-Myers Squibb (← links)
- Management of the thrombotic lesion (← links)
- Nosebleed (patient information) (← links)
- Peripheral arterial disease (patient information) (← links)
- Sticky platelet syndrome (← links)
- Clopidogrel detailed information (redirect to section "Pharmacology") (← links)
- WikiDoc state of the art review on Clopidogrel (redirect page) (← links)
- Paroxetine drug interactions (← links)
- Phenytoin drug interactions (← links)
- Hydrocodone drug interactions (← links)
- Glimepiride drug interactions (← links)
- Ramatroban (← links)
- Clopidogrel drug interactions (redirect to section "Drug Interactions") (← links)
- Celecoxib drug interactions (← links)
- Cilostazol (← links)
- Amiodarone (tablet) (← links)
- Aggrenox drug interactions (← links)
- Amlodipine and Atorvastatin drug interactions (← links)
- Epoprostenol detailed information (← links)
- Tenecteplase detailed information (← links)
- Naproxen drug interactions (← links)
- Duloxetine drug interactions (← links)
- Coronary revascularization (← links)
- Clarithromycin drug interactions (← links)
- Clopidogrel indications (redirect to section "Adult Indications and Dosage") (← links)
- Clopidogrel contraindications (redirect to section "Contraindications") (← links)
- Clopidogrel side effects (redirect to section "Adverse Reactions") (← links)
- Clopidogrel precautions (redirect to section "Precautions") (← links)
- Clopidogrel overdose (redirect to section "Overdosage") (← links)
- Clopidogrel instructions for administration (redirect to section "Administration and Monitoring") (← links)
- Clopidogrel how supplied (redirect to section "How Supplied") (← links)
- Clopidogrel pharmacokinetics and molecular data (redirect to section "Pharmacokinetics") (← links)
- The On-Time 2 trial Suggests Benefit with Early Administration of Tirofiban in the Ambulance following Acute Myocardial Infarction. (← links)
- Adenosine A2A receptor (← links)
- ST elevation myocardial infarction epidemiology and demographics (← links)
- HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study (← links)
- High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study (← links)
- Unstable angina non ST elevation myocardial infarction overview (← links)
- The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIb Guidelines (← links)
- Thienopyridine (← links)
- The list of drugs may cause diarrhea (← links)